With the overall aim of establishing an overarching national pharmaceutical framework to help guide policy reform this report has 3-key objectives: 1) To undertake a mapping of the key trends and ...

Groups covering the pharma, biotech and generics industries have come together to raise their concerns about the growing cost of monitoring drug safety in Europe. A total of five associations ...

Christoph Krähenbühl reviews the final draft Delegated Act (DA) and summarises the key actions for pharma companies. The final draft of the EU-Falsified Medicines Directive 'Safety Features ...

Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy ... Relative safety and efficacy could only be assessed ...

The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The study program combines ...

Students acquire in- depth knowledge in various fields of Pharmaceutical Sciences and gain scientific skills and insight into drug development prozess. Compulsory subjects, electives and a research ...

As technology advances and regulatory scrutiny intensifies, it is critical to ensure the safety and authenticity of ...

This course is available as an outside option to students on other programmes where regulations permit. The aim of this course is to introduce students to the economics of pharmaceutical markets and ...

To address this problem, Lantern Pharma is reinventing the cancer drug ... clinical efficacy, and safety. The second stage consists of lab genomic analysis of patient samples and genetic models.

Many promising preclinical and clinical trial programs are terminated for reasons unrelated to science, drug efficacy, or safety. Each year, the pharmaceutical industry terminates hundreds ...

The delegation, led by Alisher Temirov, Director of the Center for Pharmaceutical Products Safety, Uzbekistan, had detailed discussions with Ranga Chandrashekar, Joint Drugs Controller of India ...

The Master ́s Programme in Pharmaceutical Research, Development and Safety takes two years of full-time studies to complete. The academic activities conducted based on a personal study plan sum 120 ...